Investigating Cancer Drug Toxicity Leads to a Critical Discovery
La Jolla Institute for ImmunologyWhen patients in the UK started showing adverse side effects during a cancer immunotherapy trial, researchers at La Jolla Institute for Immunology (LJI) Center for Cancer Immunotherapy and University of Liverpool went back through the data and worked with patient samples to see what went wrong.